PARAMOUNT: Descriptive Subgroup Analyses of Final Overall Survival for the Phase III Study of Maintenance Pemetrexed versus Placebo Following Induction Treatment with Pemetrexed Pl...

Por Reck, Martin, Paz-Ares, Luis G., de Marinis, Filippo, Molinier, Olivier, Sahoo, Tarini Prasad, Laack, Eckart, John, William, Zimmermann, Annamaria H., Visseren-Grul, Carla, Gridelli, Cesare
Publicado em 2014

MSH2/BRCA1 expression as a DNA-repair signature predicting survival in early–stage lung cancer patients from the IFCT-0002 Phase 3 Trial

Por Levallet, Guénaëlle, Dubois, Fatéméh, Fouret, Pierre, Antoine, Martine, Brosseau, Solenn, Bergot, Emmanuel, Beau-Faller, Michèle, Gounant, Valérie, Brambilla, Elisabeth, Debieuvre, Didier, Molinier, Olivier, Galateau-Sallé, Françoise, Mazieres, Julien, Quoix, Elisabeth, Pujol, Jean-Louis, Moro-Sibilot, Denis, Langlais, Alexandra, Morin, Franck, Westeel, Virginie, Zalcman, Gérard
Publicado no Oncotarget (2016)